Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
63.70
+0.09 (0.14%)
At close: Aug 12, 2026, 4:00 PM EDT
63.67
-0.03 (-0.05%)
After-hours: Aug 12, 2026, 5:27 PM EDT
BMY Market Cap
BMY has a market cap or net worth of $130.12 billion as of August 12, 2026. Its market cap has increased by 39.19% in one year.
Market Cap
130.12B
Enterprise Value
163.71B
1-Year Change
39.19%
Ranking
Category
Stock Price
$63.70
ChartMarket Cap Chart
Since December 1, 1998, BMY's market cap has increased from $124.14B to $130.12B, an increase of 4.82%. That is a compound annual growth rate of 0.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 130.12B | 18.50% |
| Dec 31, 2025 | 109.81B | -4.28% |
| Dec 31, 2024 | 114.71B | 9.88% |
| Dec 29, 2023 | 104.40B | -31.75% |
| Dec 30, 2022 | 152.98B | 10.54% |
| Dec 31, 2021 | 138.39B | -1.27% |
| Dec 31, 2020 | 140.17B | 34.03% |
| Dec 31, 2019 | 104.58B | 23.27% |
| Dec 31, 2018 | 84.84B | -15.41% |
| Dec 29, 2017 | 100.30B | 2.69% |
| Dec 30, 2016 | 97.67B | -14.90% |
| Dec 31, 2015 | 114.76B | 17.20% |
| Dec 31, 2014 | 97.92B | 11.89% |
| Dec 31, 2013 | 87.51B | 62.68% |
| Dec 31, 2012 | 53.80B | -9.91% |
| Dec 30, 2011 | 59.72B | 31.75% |
| Dec 31, 2010 | 45.33B | -9.38% |
| Dec 31, 2009 | 50.02B | 8.68% |
| Dec 31, 2008 | 46.03B | -12.28% |
| Dec 31, 2007 | 52.47B | 1.36% |
| Dec 29, 2006 | 51.76B | 15.13% |
| Dec 30, 2005 | 44.96B | -9.80% |
| Dec 31, 2004 | 49.85B | -10.13% |
| Dec 31, 2003 | 55.46B | 23.69% |
| Dec 31, 2002 | 44.84B | -54.56% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AbbVie | 438.43B |
| Merck & Co. | 320.86B |
| Novartis AG | 297.85B |
| AstraZeneca | 251.46B |
| Amgen | 223.83B |
| Novo Nordisk | 209.18B |
| Gilead Sciences | 168.18B |
| Pfizer | 151.24B |